Author

Grant Blackmon

A molecular biologist in an academic gene therapy program in Fayetteville, Arkansas, Grant Blackmon develops viral vectors and engineered RNA payloads for targeted gene delivery. During his postdoctoral fellowship, he investigated lipid delivery platforms and recombinant viral systems to carry therapeutic genetic material into tissue. His current laboratory work centers on refining expression cassettes and evaluating how modified transcripts behave inside mammalian cells. Blackmon received a BS in Biology from Miami University and finished a PhD in Molecular Genetics at the Medical University of South Carolina.

SBOL: The Standard Language for Biological Design
CMV Promoter: Current Insights into Gene Expression Control
How scGen Uses AI to Predict Cellular Response
The Site Saturation Mutagenesis Process and Applications
The Functions of AAV VP1, VP2, and VP3 Proteins
What Is Tn-Seq? Process and Key Applications
What Is N1-Methylpseudouridine and How Does It Work?
Molecular Cloning Protocol: A Step-by-Step Explanation
LNP Endosomal Escape: A Critical Step for Therapeutics
What Is the 3′ RACE Technique in Molecular Biology?
What Are RNAscope Probes and How Do They Work?
Tracing RNA Synthesis Using 14C-Uracil Labeling Techniques
AAV Serotypes: Structure, Tropism, and Immune Evasion
BacMam Mechanism, Vector Composition, and Scale-Up Advances
AAV Packaging Processes: Roles and Techniques
Proline Biosynthesis: Pathways, Regulation, and Engineering
AAV Empty/Full Ratio: Why It Matters for Gene Delivery
smFISH: A Detailed Approach to Single-Molecule RNA Detection
Spinoculation: Current Insights for Viral Transduction
AAV Purification Methods: Ensuring Quality and Yield
Insights Into the hsyn Promoter for Neuron-Specific Expression